Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Wanghua Pharmaceutical is a specialized pharmaceutical manufacturer based in Hangzhou, China, focusing on Traditional Chinese Medicine (TCM) and topical treatments for gynecological and dermatological health. Founded in 1994, the company is best known for its flagship commercial products, the Baidaijing Capsule (白带净胶囊) and Fuqin Lotion (肤芩洗剂), which are used for their anti-inflammatory, analgesic, and antibacterial properties in treating reproductive tract infections. The company operates a GMP-certified manufacturing site in the Tonglu Economic Development Zone and serves the domestic Chinese market by providing specialized remedies for inflammatory and pruritic conditions. Its recent activities include the renewal of its pharmaceutical manufacturing license in 2025, ensuring its continued presence in the regional pharmaceutical sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Wanghua Pharmaceutical.